CONFLICT OF INTEREST STATEMENT Jorge Hernando has served on speakers' bureaux and advisory boards for Novartis, Ipsen, Advanz, Eisai, Lilly and Esteve. Wouter W. de Herder has received honoraria for speaking engagements and/or advisory boards from Camurus, Ipsen, Novartis and Recordati.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Jorge Hernando
A multistakeholder call for belzutifan biomarker data in advanced pheochromocytoma and paraganglioma
|
By Rodrigo A. Toledo, Carlota Arenillas, Patricia Dahia, Judith Favier, Mercedes Robledo, Anand T. Vaidya, Henri J. Timmers, Cristina L. Ronchi, Frederic Castinetti, Roderick J Clifton-Bligh, Christina Pamporaki, Ruth Casey, Madson Q Almeida, Louis J. Maher, Hussam Alkaissi, Jorge Hernando, Akiyo Tanabe, Isabelle Bourdeau, Marta Araujo-Castro, Anna-Karin Gustavsson, Joanna Grey, Anna Greene, Aaron Hansen, Irina Bancos, Scott A. Akker, William Young, Svenja Nölting, Hans K. Ghayee, Graeme Eisenhofer, Jacques W.M. Lenders, Karel Pacak, Cynthia M. Estrada-Zúñiga, Amanda Dusing, Mar Ayllón
|
Cell Press
Verified
Keywords belzutifan HIF-2α biomarker pheochromocytoma paraganglioma Belzutifan for advanced pheochromocytoma/paraganglioma: A milestone for rare cancers Completion of the LITESPARK-015 trial (NCT04924075i) and the U.S. Food and Drug Administration (FDA) approval of belzutifan represent a landmark for patients with advanced pheochromocytoma/paraganglioma (PPGL)ii and, more broadly, for the rare cancer community.
Durvalumab plus tremelimumab for the treatment of patients with progressive, refractory advanced thyroid carcinoma: the phase II GETNE-DUTHY trial
|
By Jaume Capdevila, Jorge Hernando, María Plana Serrahima, Beatriz Castelo, Cristina Álvarez-Escola, Alberto Carmona-Bayonas, Inmaculada Navarro, Lara Romero Iglesias, Mateo Bover, Alejandro Garcia-Alvarez, Javier Lavernia, Sofia Ruiz, Sofía Ruiz, Neus Basté, Enrique Sanz-Garcia, Gloria Marquina, Paolo Nuciforo, Enrique Grande, Teresa Alonso-Gordoa, Javier Molina-Cerillo, Miren Taberna Sanz, Ricardo Yayá Tur, Isabel Lorenzo-Lorenzo, Alfredo Sanchez-Hernandez, Belén Elguero
|
Nature
Verified
Abstract Single-agent PD-1 blockade demonstrated promising efficacy in advanced thyroid cancer. The phase II, single-arm, multi-cohort GETNE-DUTHY trial (clinicaltrials.gov NCT03753919, EudraCT 2018-001066-42) aimed to determine whether dual anti-PD-L1/CTLA-4 inhibition using durvalumab and tremelimumab can improve the clinical outcomes in advanced thyroid cancer.
Parámetros fisiológicos en caninos pre y post competencia de Agility en Bogotá, Colombia
Ayuda Buscar en la ayuda Buscar en la ayuda Parámetros fisiológicos en caninos pre y post competencia de Agility en Bogotá, Colombia Autores: Jorge Hernando Forero López, Paola Andrea Lozano Martínez, Boris Orlando Camargo Roncancio Localización: Revista de Medicina Veterinaria, ISSN 0122-9354, Nº. 18, 2009, págs.
Frontiers | Case Report: Lorlatinib for the treatment of ALK-rearranged poorly differentiated thyroid carcinoma after progression to prior ALK-specific tyrosine-kinase inhibitor
Abstract ALK rearrangements are rare but actionable oncogenic drivers in thyroid cancer, particularly in aggressive histologies such as poorly differentiated thyroid carcinoma (PDTC), and evidence supporting sequential ALK inhibition in this setting is scarce. We report a 19-year-old male with ALK-rearranged, radioiodine-refractory PDTC who started systemic therapy with ceritinib, achieving a complete metabolic response.
El animal divino: Desnaturalización de lo “humano” y construcción del “Otro” animal
Ayuda Buscar en la ayuda Buscar en la ayuda El animal divino: Desnaturalización de lo “humano” y construcción del “Otro” animal Autores: Jorge Hernando Pacheco Gómez Localización: Desde el jardín de Freud: revista de psicoanálisis, ISSN-e 2256-5477, ISSN 1657-3986, Nº. 23-24, 2024 (Ejemplar dedicado a: El animal de mira), págs.
Consideraciones de los tratamientos nutricionales para patologías de origen gastrointestinal en el paciente felino
Ayuda Buscar en la ayuda Buscar en la ayuda Consideraciones de los tratamientos nutricionales para patologías de origen gastrointestinal en el paciente felino Autores: Jorge Hernando Localización: Canis et felis, ISSN 1133-2751, Nº. 182, 2023, págs. 23-31 Idioma: español Texto completo no disponible (Saber más ...)
El índice de fragilidad y sus características en ensayos clínicos aleatorizados de diabetes mellitus
Ayuda Buscar en la ayuda Buscar en la ayuda El índice de fragilidad y sus características en ensayos clínicos aleatorizados de diabetes mellitus David Benavides-Zora [1] ; Sara Vásquez-Martínez [1] ; Jorge Hernando Donado Gómez [2] [1] Universidad CES, Colombia. [2] Universidad de Antioquia Localización: Revista CES Medicina, ISSN-e 2215-9177, ISSN 0120-8705, Vol. 36, Nº. 2, 2022, págs.
Consenso multidisciplinar acerca del manejo de tratamientos de ortodoncia en pacientes oncológicos
Ayuda Buscar en la ayuda Buscar en la ayuda Consenso multidisciplinar acerca del manejo de tratamientos de ortodoncia en pacientes oncológicos Hernando, Jorge [1] ; González, Laura [1] ; Salvá, Clara [1] ; Álvarez, Raquel [1] ; Moyano, Javier [2] [1] Hospital Vall d´Hebron, Barcelona [2] Universitat Internacional de Catalunya Localización: Ortodoncia española: Boletín de la Sociedad Española de Ortodoncia, ISSN 0210-1637, Vol. 62, Nº. 3, 2024, págs.
A CT-based deep learning-driven tool for automatic liver tumor detection and delineation in patients with cancer
|
By Adria Marcos Morales, Marta Ligero, David Leiva, Cristina Viaplana, Joaquin Mateo, Jorge Hernando, Alejandro Garcia-Alvarez, Francesc Salvà, Jaume Capdevila, Elena Elez, Rodrigo Dienstmann, Elena Garralda, Raquel Perez-Lopez, Maria Balaguer-Montero, Christina Zatse, Luz M. Atlagich, Nikolaos Staikoglou, Camilo Monreal
|
Cell Reports Medicine
Verified
ArticleOnline now102032Open access 1Radiomics Group, Vall d’Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain 2Else Kroener Fresenius Center for Digital Health, Medical Faculty Carl Gustav Carus, TUD Dresden University of Technology, 01307 Dresden, Germany 3Bellvitge University Hospital, 08907 Barcelona, Spain 4Oncocentro Apys, Viña Del Mar 2520598, Chile 5Oncology Data Science (ODysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain 6Department of Medical...
Corrigendum to “Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours” [Eur J Cancer 188 (2023) 39-48] - European Journal of Cancer
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
VEIN STEP: A Prospective, Observational, International Study to Assess Effectiveness of Conservative Treatments in Chronic Venous Disease
Advances in Therapy, Sep 2023 VEIN STEP was conducted to collect international data on the management of chronic venous disease (CVD) and to assess the effectiveness of conservative treatments for the relief of CVD signs and symptoms. This international, observational, prospective, longitudinal, cohort study recruited adult outpatients consulting for symptomatic CVD.
Influencia térmica en el curado de hormigones con y sin aditivos aceleradores de fraguado, analizados con el método de la madurez.
[ES] El método de la madurez es un método no destructivo de control de la resistencia del hormigón, que se basa en la temperatura interna de la pieza, debida tanto a las condiciones ambientales, como a las temperaturas ...[+] [ES] El método de la madurez es un método no destructivo de control de la resistencia del hormigón, que se basa en la temperatura interna de la pieza, debida tanto a las condiciones ambientales, como a las temperaturas provenientes de la reacción química propia del...
VEIN STEP: A Prospective, Observational, International Study to Assess Effectiveness of Conservative Treatments in Chronic Venous Disease - Advances in Therapy
Abstract VEIN STEP was conducted to collect international data on the management of chronic venous disease (CVD) and to assess the effectiveness of conservative treatments for the relief of CVD signs and symptoms. This international, observational, prospective, longitudinal, cohort study recruited adult outpatients consulting for symptomatic CVD.
Meta‐Analysis of Randomized Clinical Trials Comparing Active Treatment with Placebo in Metastatic Neuroendocrine Tumors
Advertisement Advertisement Jaume Capdevila (jacapdevila{at}vhebron.net)*,a, Jorge Hernandoa, Santiago Perez‐Hoyosb, Alejandro Roman‐Gonzalezc and Enrique Granded a Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain b Biostatistics and Bioinformatics Unit, Vall d'Hebron Research Institute, Barcelona, Spain c Department of Endocrinology, San Vicente Fundacion University Hospital‐Antioquia University, Medellin, Colombia d...
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Jorge
Contact Jorge, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack